AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Purchase
+$87,600
+10.13%
Shares
Shares Volume: 60,000 Shares
Average Share Price: $1.46
INSIDER
Readnour Robin Shane
Director
reported on Dec 10 2024
traded on Dec 6 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 652,573 |
| PURCHASES/SALES 1Y | 3 / 2 |
| P/S VALUE RATIO | 3.701 |
| AVERAGE PURCHASE VALUE | $137,783.33 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 2 / 0 |
| PURCHASES/SALES 1Y | 7 / 11 |
| P/S VALUE RATIO | 0.205 |
| AVERAGE PURCHASE VALUE | $293,021.43 |
| COMPANY PREVIOUS TRADES |